4.01

8.03% -0.35

Pre-market: 4.01

Taysha Gene Therapies Inc (TSHA)

Overview News Price History Option Chain Financials Discussions Forecast

Taysha Gene Therapies Inc stock is traded at $4.01, with a volume of 3.70M. It is down -8.03% in the last 24 hours and down -20.59% over the past month. Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Previous Close:

$4.36

Open:

$4.35

24h Volume:

3.70M

Relative Volume:

0.60

Market Cap:

$1.09B

Revenue:

$8.10M

Net Income/Loss:

$-92.72M

P/E Ratio:

-11.23

EPS:

-0.3571

Net Cash Flow:

$-82.52M

1W Performance:

+2.30%

1M Performance:

-20.59%

6M Performance:

+71.37%

1Y Performance:

+81.45%

1-Day Range:

$3.98

$4.35

1-Week Range:

$3.6929

$4.495

52-Week Range:

$1.05

$5.5082

Taysha Gene Therapies Inc Stock (TSHA) Company Profile

Name

Taysha Gene Therapies Inc

Sector

Healthcare (1103)

Industry

Biotechnology (618)

Phone

(214) 612-0000

Address

3000 PEGASUS PARK DRIVE, DALLAS

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

TSHA's Discussions on Twitter

Compare TSHA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TSHA Taysha Gene Therapies Inc	4.01	1.19B	8.10M	-92.72M	-82.52M	-0.3571
VRTX Vertex Pharmaceuticals Inc	434.52	110.16B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	694.99	71.65B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	453.97	59.81B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	891.73	54.79B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	368.36	41.77B	4.98B	69.59M	525.67M	0.5197

Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-21-25	Initiated	Raymond James	Strong Buy
Jul-11-25	Initiated	BofA Securities	Buy
Jun-27-24	Initiated	BMO Capital Markets	Outperform
Apr-09-24	Initiated	Piper Sandler	Overweight
Feb-01-23	Downgrade	Jefferies	Buy → Hold
Jan-27-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-09-22	Downgrade	Goldman	Buy → Neutral
Mar-09-22	Initiated	Robert W. Baird	Outperform
Mar-01-22	Initiated	Wells Fargo	Overweight
Feb-18-22	Initiated	SMBC Nikko	Outperform
Dec-16-21	Initiated	Guggenheim	Buy
Jul-16-21	Initiated	Needham	Buy
Jun-24-21	Initiated	Truist	Buy
Jun-15-21	Initiated	BTIG Research	Buy
Jun-09-21	Initiated	Wedbush	Outperform
Jun-08-21	Initiated	JMP Securities	Mkt Outperform
May-19-21	Initiated	Cantor Fitzgerald	Overweight
May-11-21	Resumed	Jefferies	Buy
Feb-24-21	Initiated	William Blair	Outperform
Jan-05-21	Initiated	Oppenheimer	Outperform
Oct-19-20	Initiated	Chardan Capital Markets	Buy
Oct-19-20	Initiated	Goldman	Buy
Oct-19-20	Initiated	Jefferies	Buy
Oct-19-20	Initiated	Morgan Stanley	Overweight

View All

Taysha Gene Therapies Inc Stock (TSHA) Latest News

12:26 PM

Is Taysha Gene Therapies Inc. stock near bottom after decline2025 Earnings Impact & Expert Approved Momentum Trade Ideas - newser.com

12:26 PM

Nov 13, 2025

Using Bollinger Bands to evaluate Taysha Gene Therapies Inc.2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com

Nov 13, 2025

Will Taysha Gene Therapies Inc. stock recover after recent drop2025 Earnings Surprises & Fast Momentum Entry Tips - newser.com

Nov 13, 2025

Taysha Gene Therapies Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics - Markets Mojo

Nov 13, 2025

Short interest data insights for Taysha Gene Therapies Inc.2025 EndofYear Setup & High Conviction Trade Alerts - newser.com

Nov 13, 2025

Nov 12, 2025

Custom watchlist performance reports with Taysha Gene Therapies Inc.July 2025 Price Swings & High Return Trade Guides - newser.com

Nov 12, 2025

Can Taysha Gene Therapies Inc. hit a new high this monthJuly 2025 Catalysts & Weekly Momentum Picks - newser.com

Nov 12, 2025

How Taysha Gene Therapies Inc. stock benefits from strong dollar2025 Biggest Moves & Stock Portfolio Risk Control - newser.com

Nov 12, 2025

Nov 11, 2025

Commit To Purchase Taysha Gene Therapies At $2.50, Earn 24% Using Options - Nasdaq

Nov 11, 2025

Detecting support and resistance levels for Taysha Gene Therapies Inc.2025 Key Highlights & High Return Stock Watch Alerts - newser.com

Nov 11, 2025

Nov 10, 2025

Candlestick signals on Taysha Gene Therapies Inc. stock todayBuy Signal & Accurate Entry and Exit Point Alerts - newser.com

Nov 10, 2025

Nov 09, 2025

Will breakout in Taysha Gene Therapies Inc. lead to full recoveryPortfolio Performance Report & Technical Pattern Based Signals - newser.com

Nov 09, 2025

How institutional ownership impacts Taysha Gene Therapies Inc. stockWeekly Risk Report & Free Risk Controlled Daily Trade Plans - newser.com

Nov 09, 2025